Abstract
Obstructive sleep apnea/hypopnea syndrome (OSAS) is a relatively new disease which is proven to be a major cause of morbidity and mortality worldwide and a huge problem for public health. Type 2 diabetes (T2DM) is another disease which is worldwide seen as an epidemic. The link between these two conditions makes it more important to provide a proper treatment option for such patients in order to prevent life threatening complications. This article is an up-to-date review of the relationship between OSAS and T2DM, diagnostic procedures and treatment options for patients who have both of the diseases since every particular case may be adjusted differently and may benefit from a multiple line treatment.
Keywords: Obstructive sleep apnea, glucose metabolism, type 2 diabetes mellitus.
Current Respiratory Medicine Reviews
Title:Obstructive Sleep Apnea and Type 2 Diabetes: Dual Interaction
Volume: 11 Issue: 4
Author(s): Alexandru Corlateanu, Victor Botnaru, Victoria Sircu, Serghei Covantev and Gloria Montanari
Affiliation:
Keywords: Obstructive sleep apnea, glucose metabolism, type 2 diabetes mellitus.
Abstract: Obstructive sleep apnea/hypopnea syndrome (OSAS) is a relatively new disease which is proven to be a major cause of morbidity and mortality worldwide and a huge problem for public health. Type 2 diabetes (T2DM) is another disease which is worldwide seen as an epidemic. The link between these two conditions makes it more important to provide a proper treatment option for such patients in order to prevent life threatening complications. This article is an up-to-date review of the relationship between OSAS and T2DM, diagnostic procedures and treatment options for patients who have both of the diseases since every particular case may be adjusted differently and may benefit from a multiple line treatment.
Export Options
About this article
Cite this article as:
Corlateanu Alexandru, Botnaru Victor, Sircu Victoria, Covantev Serghei and Montanari Gloria, Obstructive Sleep Apnea and Type 2 Diabetes: Dual Interaction, Current Respiratory Medicine Reviews 2015; 11 (4) . https://dx.doi.org/10.2174/1573398X11666150915212520
DOI https://dx.doi.org/10.2174/1573398X11666150915212520 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of Endothelin System in Cardiovascular Disease and the Potential Therapeutic Perspectives of its Inhibition
Current Topics in Medicinal Chemistry Pleiotropic Effects of Simvastatin on Some Calcium Regulatory and Myofibrillar Proteins in Ischemic/Reperfused Heart: Causality of Statins Cardioprotection?
Current Pharmaceutical Design A Diabetes Treatment Strategy to Reduce the Risk of Cardiovascular Events: Clinical Benefits and Potential of Linagliptin
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Platelet Resistance to the Anti-Aggregating Agents in the Insulin Resistant States
Current Diabetes Reviews Enhancing Cardiovascular Dynamics by Inhibition of Thrombospondin- 1/CD47 Signaling
Current Drug Targets Bile Acids and Farnesoid X Receptor: Novel Target for the Treatment of Diabetic Cardiomyopathy
Current Protein & Peptide Science Gene Therapy to Improve High-Density Lipoprotein Metabolism and Function
Current Pharmaceutical Design Clinically Relevant Extracellular-Matrix Scaffolds for Cell Transplantation and Vascular Repair
Current Vascular Pharmacology Implication of Gut Microbiota in Human Health
CNS & Neurological Disorders - Drug Targets Interleukin-6 In Rheumatoid Arthritis - From The Laboratory To The Bedside
Current Pharmaceutical Design Discovery of Anticoagulant Drugs: A Historical Perspective
Current Drug Discovery Technologies Is There a Genetic Susceptibility to Bronchopulmonary Dysplasia?
Current Respiratory Medicine Reviews Genes Involved in Hereditary Hearing Impairment
Current Genomics Advent and Maturation of Regenerative Medicine
Current Stem Cell Research & Therapy Beta-Blockers: Current State of Knowledge and Perspectives
Mini-Reviews in Medicinal Chemistry Pharmacogenetics of HMG-CoA Reductase Inhibitors: Optimizing the Prevention of Coronary Heart Disease
Current Pharmacogenomics and Personalized Medicine Recent Patent in Controlled Porosity Osmotic Pump
Recent Patents on Drug Delivery & Formulation Coronary Microcirculation in Ischemic Heart Disease
Current Pharmaceutical Design G-Lymphatic, Vascular and Immune Pathways for Aβ Clearance Cascade and Therapeutic Targets For Alzheimer’s Disease
Combinatorial Chemistry & High Throughput Screening Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)